GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $877,272 | -57.1% | 1,053,400 | -38.1% | 0.00% | -60.0% |
| Q2 2023 | $2,043,480 | -11.9% | 1,702,900 | -7.5% | 0.01% | -16.7% |
| Q1 2023 | $2,318,904 | -41.4% | 1,840,400 | +0.9% | 0.01% | -45.5% |
| Q4 2022 | $3,959,599 | -61.9% | 1,824,700 | +110.3% | 0.01% | -63.3% |
| Q3 2022 | $10,395,000 | +307.0% | 867,700 | +184.4% | 0.03% | +328.6% |
| Q2 2022 | $2,554,000 | -1.2% | 305,100 | +2.5% | 0.01% | 0.0% |
| Q1 2022 | $2,585,000 | -13.8% | 297,800 | +12.3% | 0.01% | -12.5% |
| Q4 2021 | $2,999,000 | +17.2% | 265,200 | +30.3% | 0.01% | +14.3% |
| Q3 2021 | $2,559,000 | -12.2% | 203,600 | -43.2% | 0.01% | -12.5% |
| Q2 2021 | $2,913,000 | -35.8% | 358,700 | -26.8% | 0.01% | -33.3% |
| Q1 2021 | $4,534,000 | +133.5% | 490,200 | +144.1% | 0.01% | +140.0% |
| Q4 2020 | $1,942,000 | +3.9% | 200,800 | +33.2% | 0.01% | 0.0% |
| Q3 2020 | $1,870,000 | +167.9% | 150,700 | +180.6% | 0.01% | +150.0% |
| Q2 2020 | $698,000 | – | 53,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |